A surface-exposed lipoprotein expressed by >95% of serogroup B strains .
Vaccine utility: Trumenba® contains lipidated fHbp variants from subfamilies A and B, inducing bactericidal antibodies against diverse strains .
A lipoprotein present in all N. meningitidis serogroup B strains .
Vaccine design: Recombinant LP2086 (rLP2086) elicits cross-reactive bactericidal antibodies, with two subfamilies (A and B) providing broad coverage .
RimP in *N. meningitidis*: No direct studies on RimP’s role in meningococcal ribosome biogenesis or its potential as a vaccine target exist in the provided literature.
Antigen synergy: Combining RimP-like ribosomal factors with surface antigens (e.g., fHbp) could enhance vaccine efficacy, as seen with LP2086 + PorA combinations .
Structural insights: Crystal structures of RimP homologs (e.g., MSMEG_2624) may guide drug design against ribosomal targets in M. tuberculosis, with potential applicability to other pathogens .
KEGG: nme:NMB1641
STRING: 122586.NMB1641
RimP (Ribosome Maturation Factor P) is an essential protein involved in ribosomal biogenesis, specifically in the formation of the 30S small ribosomal subunit in bacteria. In Neisseria meningitidis, as in other bacterial species, RimP plays a critical role in ensuring proper assembly of ribosomes, which are essential for protein synthesis . Research indicates that in the absence of RimP, the central pseudoknot structure of rRNA becomes unstable, leading to the accumulation of immature ribosomal intermediates that lack crucial ribosomal proteins such as S5 and S12 .
Experimental approaches to characterize RimP function typically involve gene knockout or depletion studies followed by ribosomal profiling to assess the impact on 30S subunit assembly. Complementation experiments can confirm function by restoring wild-type RimP expression in knockout strains. Polysome profile analysis and ribosome sedimentation studies are valuable methodologies for assessing ribosomal assembly defects that occur in the absence of functional RimP.
Structural studies of RimP homologs, particularly the high-resolution crystal structure from Mycobacterium smegmatis, reveal that RimP contains two distinct domains with a well-defined interdomain orientation . These domains cooperatively bind with the small ribosomal protein RpsL (S12) through RimP's linker region, which appears to be essential for proper ribosomal biogenesis .
The linker region contains evolutionarily conserved residues that form a platform for recruiting S12 and facilitating rRNA binding . When examining RimP structure-function relationships, researchers should consider:
Domain interactions and their cooperative binding mechanisms
Conservation of critical residues across bacterial species
Specific binding interfaces with ribosomal proteins and rRNA
Conformational changes that might occur during ribosome assembly
X-ray crystallography, cryo-electron microscopy, and protein-protein interaction studies using methods such as surface plasmon resonance can provide insights into these structural aspects.
For successful expression and purification of recombinant Neisseria meningitidis RimP, researchers should consider the following methodological approach:
Gene cloning: The rimP gene should be amplified from N. meningitidis genomic DNA using PCR with appropriate primers containing restriction sites for subsequent cloning into an expression vector .
Expression system selection: Escherichia coli expression systems are commonly used for recombinant bacterial protein production. BL21(DE3) strains are generally suitable for RimP expression .
Vector selection: pET-based vectors with histidine tags facilitate purification using metal affinity chromatography. The optimal tag position (N- or C-terminal) should be determined empirically.
Expression conditions: Induction with IPTG (isopropyl β-D-1-thiogalactopyranoside) at concentrations between 0.1-1.0 mM when cultures reach OD600 0.6-0.8, followed by incubation at lower temperatures (16-25°C) can improve soluble protein yield .
Purification strategy: Ni-NTA affinity chromatography is effective for His-tagged RimP purification, followed by size exclusion chromatography to achieve higher purity .
Protein verification: SDS-PAGE and western blotting with anti-His antibodies confirm successful expression and purification .
For difficult-to-express proteins, alternative approaches include fusion partners (MBP, GST, SUMO), different E. coli strains (Rosetta for rare codon optimization), or cell-free expression systems.
The interaction between RimP and ribosomal proteins, particularly RpsL (S12), is crucial for proper 30S subunit assembly. Based on structural and biochemical studies of RimP homologs, the linker region between the two domains of RimP forms a platform for recruiting S12 and facilitating its association with the central pseudoknot structure of 16S rRNA .
Research suggests that in the absence of RimP, the central pseudoknot structure becomes unstable, leading to accumulation of assembly intermediates that lack critical pseudoknot-interacting ribosomal proteins S5 and S12 . This implies a sequential assembly model where:
RimP binds to nascent 16S rRNA
RimP recruits S12 through its conserved linker region
S12 association stabilizes the central pseudoknot structure
Additional proteins (including S5) can then properly associate
RimP likely dissociates after facilitating these interactions
To study these interactions, researchers can employ:
Pull-down assays with tagged RimP to identify interacting ribosomal proteins
In vitro reconstitution experiments with purified components
Structural studies using cryo-EM to visualize assembly intermediates
Mutational analysis of the linker region to identify critical residues
Time-resolved experiments to map the kinetics of assembly
The cooperative nature of these interactions suggests that disruption of RimP function would have cascading effects on ribosome assembly and ultimately bacterial viability.
While direct evidence linking RimP to antibiotic resistance mechanisms in Neisseria meningitidis is limited in the provided search results, several conceptual connections can be made that warrant investigation:
Rifampicin resistance: Studies have identified rifampicin-resistant N. meningitidis isolates (0.20% fully resistant with MIC >1 mg/L and 0.69% intermediate-resistant with MICs between 0.38-1 mg/L) . Rifampicin targets RNA polymerase, affecting transcription rather than translation directly, but altered ribosome assembly due to RimP dysfunction could potentially influence susceptibility to translation-targeting antibiotics.
Altered ribosome composition: Since RimP plays a role in proper 30S subunit assembly, mutations or expression changes in RimP could theoretically lead to altered ribosome composition or structure that might affect binding of translation-targeting antibiotics.
Stress response: Ribosome assembly defects caused by RimP dysfunction could trigger bacterial stress responses that may indirectly contribute to antibiotic tolerance.
Research methodologies to investigate these relationships should include:
Comparative genomic analysis of rimP sequences in antibiotic-resistant versus susceptible isolates
Transcriptomic and proteomic profiling of antibiotic-resistant strains to assess RimP expression levels
Generation of RimP overexpression and depletion strains to test antibiotic susceptibility changes
Structural studies to determine if RimP-dependent alterations in ribosome assembly affect antibiotic binding sites
| Resistance Category | Number of Isolates | Percentage | MIC Range |
|---|---|---|---|
| Sensitive | 3869 | 99.11% | <0.38 mg/L |
| Intermediate | 27 | 0.69% | 0.38-1 mg/L |
| Resistant | 8 | 0.20% | >1 mg/L |
| Total | 3904 | 100% | - |
Data from the French Meningococcal Reference Centre
Effective experimental design for studying RimP function in N. meningitidis should incorporate three key principles: randomization, replication, and blocking3.
Randomization: To minimize bias, researchers should randomize:
Selection of bacterial strains for genetic manipulation
Assignment of treatment conditions
Order of sample processing and analysis
Selection of timepoints for data collection
Replication: Proper replication ensures robust and reliable results3:
Biological replicates: Use multiple independent bacterial cultures grown from different colonies
Technical replicates: Repeat measurements from the same biological sample
Temporal replication: Repeat entire experiments on different days
Minimum recommended replication: 3 biological replicates with 2-3 technical replicates each
Blocking: Control for known sources of variability by stratifying experiments3:
Growth conditions (media batches, incubation equipment)
Genetic background (clinical isolates vs. laboratory strains)
Growth phase (exponential vs. stationary)
For RimP functional studies specifically, consider the following experimental design elements:
Gene manipulation approaches:
Clean deletion mutants with complementation controls
Conditional expression systems (inducible/repressible promoters)
Point mutations targeting conserved residues in the linker region
Phenotypic characterization:
Growth curve analysis under various conditions
Ribosome profiling using sucrose gradient centrifugation
Protein synthesis rates using radioisotope incorporation
Antibiotic susceptibility testing
Molecular interaction studies:
Co-immunoprecipitation with ribosomal proteins
Surface plasmon resonance for binding kinetics
Structural analysis by cryo-EM or X-ray crystallography
| Research Question | Approach | Controls | Measurements | Analysis Method |
|---|---|---|---|---|
| Is RimP essential? | Conditional depletion | Wild-type strain, Empty vector | Growth rate, Cell viability | Growth curve analysis, CFU counting |
| What proteins interact with RimP? | Co-immunoprecipitation | Non-specific antibody, Untagged strain | Interacting proteins | Mass spectrometry, Western blot |
| How does RimP affect ribosome assembly? | Sucrose gradient centrifugation | Wild-type, Known assembly mutants | Ribosomal subunit profiles | A260 absorbance profiles, RNA-seq of fractions |
| Which RimP residues are critical? | Site-directed mutagenesis | Wild-type, Known inactive mutant | Complementation efficiency | Growth restoration, Ribosome profiles |
| How does RimP depletion affect gene expression? | RNA-seq after conditional depletion | Wild-type, Samples at multiple timepoints | Transcriptome changes | Differential expression analysis |
Studying RimP-dependent ribosome assembly intermediates presents several technical challenges that require specialized methodological approaches:
Challenges:
Transient nature of assembly intermediates: Ribosome assembly occurs rapidly, making capture of intermediates difficult.
Heterogeneity of intermediates: Assembly does not proceed through a single pathway, resulting in diverse intermediate populations.
Low abundance: Assembly intermediates typically represent a small fraction of cellular ribosomal components.
Technical limitations: Standard techniques may not adequately separate or identify specific intermediates.
Function-structure relationships: Connecting observed structural features to functional significance is complex.
Methodological Solutions:
Strain Engineering Approaches:
Temperature-sensitive RimP mutants that allow controlled inactivation
Depletion strains using inducible/repressible systems
Strategic point mutations that slow but don't abolish function
Isolation and Characterization Methods:
Sucrose density gradient ultracentrifugation with expanded gradients
Affinity purification using tagged ribosomal proteins or RimP
Specialized ribosome profiling to capture assembly-specific signatures
Structural Analysis:
Cryo-electron microscopy with advanced particle classification
Chemical probing methods (SHAPE, DMS) to assess rRNA structure
Mass spectrometry approaches to determine protein composition
Kinetic Approaches:
Pulse-chase experiments with labeled rRNA/proteins
Time-resolved structural studies
Single-molecule tracking of assembly factors
| Method | Information Provided | Advantages | Limitations |
|---|---|---|---|
| Sucrose gradient ultracentrifugation | Sedimentation profiles of assembly intermediates | Simple technique, well-established | Limited resolution, sample dilution |
| Quantitative mass spectrometry | Protein composition of intermediates | Precise identification of components | Requires specialized equipment, complex analysis |
| Cryo-EM | Structural details of intermediates | Near-atomic resolution possible | Computationally intensive, sample preparation challenges |
| Chemical probing | RNA structure in intermediates | Can be performed in vivo | Indirect structural information, complex analysis |
| RNA-seq of gradient fractions | RNA components of intermediates | High sensitivity, transcriptome-wide | Requires significant bioinformatic analysis |
| Fluorescence-based assays | Real-time assembly dynamics | Can track assembly in vivo | Requires genetic modification, potential artifacts |
A combined approach using multiple methods provides the most comprehensive understanding of RimP's role in ribosome assembly.
Comparative analysis of RimP across bacterial species provides valuable insights into conserved functional domains and species-specific adaptations. While the search results mainly provide detailed information about RimP from Mycobacterium smegmatis , this can serve as a reference point for comparing with N. meningitidis RimP.
Structural Comparison:
The high-resolution crystal structure of M. smegmatis RimP reveals two distinct domains with a well-defined interdomain orientation . This general architecture is likely conserved in N. meningitidis RimP, but with potential differences in:
Interdomain linker length and composition
Surface charge distribution
Specific binding interfaces for ribosomal components
Presence of species-specific structural elements
Functional Conservation:
The fundamental role of RimP in 30S ribosomal subunit assembly appears conserved across bacterial species. In both E. coli and M. smegmatis, RimP is essential for proper ribosome biogenesis . The critical function of the linker region in binding ribosomal protein S12 (RpsL) and facilitating rRNA binding is likely conserved in N. meningitidis as well.
Methodological Approaches for Comparative Studies:
Sequence analysis:
Multiple sequence alignment of RimP proteins
Phylogenetic analysis to map evolutionary relationships
Conservation mapping onto structural models
Complementation studies:
Express N. meningitidis RimP in E. coli or M. smegmatis rimP deletion strains
Test functional complementation across species boundaries
Identify domains responsible for species-specific functions
Chimeric protein analysis:
Generate domain-swapped versions between species
Test functionality of chimeric proteins
Map species-specific functional regions
*Predicted based on homology and conservation patterns, not directly evidenced in search results
Given RimP's essential role in ribosome biogenesis, it represents a potential target for novel antimicrobial development against N. meningitidis. While the search results don't directly address this application, several rational approaches can be derived from current understanding:
Target Validation Approach:
Generate conditional RimP depletion strains to confirm essentiality in N. meningitidis
Validate growth inhibition upon RimP depletion under various conditions
Evaluate impact of partial inhibition on bacterial fitness and virulence
Drug Discovery Strategies:
Structure-based virtual screening using RimP crystal structure as template
Fragment-based approach targeting the linker region that interacts with S12
High-throughput screening of compound libraries using RimP-S12 binding assays
Peptide mimetics based on the binding interface
Specificity Considerations:
Compare RimP structures across bacterial pathogens and human cells
Target regions unique to bacterial RimP proteins
Design assays to assess selectivity for bacterial versus human cellular targets
Resistance Development Assessment:
Frequency of spontaneous resistance
Mechanisms of potential resistance (target modification, efflux, bypass)
Cross-resistance with existing antibiotics
| Advantages | Challenges | Mitigation Strategies |
|---|---|---|
| Essential protein without human homolog | Potential for rapid resistance development | Combination therapy approaches |
| Well-defined structure with targetable interfaces | Intracellular target requiring membrane penetration | Medicinal chemistry for improved penetration |
| Different from traditional antibiotic targets | Limited clinical precedent for ribosome assembly inhibitors | Robust in vitro and in vivo validation |
| Potential broad-spectrum activity | Species-specific structural differences | Structure-guided drug design |
| May be effective against dormant bacteria | Complex protein-protein interactions | Fragment-based approaches |
Although RimP is primarily an intracellular ribosomal assembly factor not typically considered for vaccine development, its research contributes to understanding N. meningitidis biology and potentially to vaccine approaches:
Contribution to Basic Knowledge:
Research on RimP enhances understanding of N. meningitidis gene expression machinery, potentially informing vaccine antigen design and production. The ribosomal maturation process impacts expression of all proteins, including those targeted in vaccines.
Recombinant Protein Production:
Methodologies developed for RimP expression and purification can inform production of other N. meningitidis recombinant proteins for vaccine development .
Risk Management Considerations:
Research on fundamental N. meningitidis biology contributes to risk management plans for vaccines, such as the bivalent recombinant lipoprotein vaccine discussed in search result .
Indirect Applications:
Understanding translation efficiency may help optimize expression of vaccine candidates
Identification of RimP-dependent genes may reveal new surface-exposed antigens
Knowledge of ribosome function may inform attenuation strategies for live vaccines
The search results indicate ongoing vaccine development efforts against N. meningitidis serogroup B using recombinant lipoproteins . While RimP itself is not mentioned as a vaccine component, the regulatory documentation shows systematic evaluation of:
Target population demographics
Clinical trial exposure data
Post-authorization experience
Risk management planning
Missing information identification
Genetic manipulation of N. meningitidis presents unique challenges due to this organism's natural competence, specific growth requirements, and transformation barriers. For rimP modification, researchers should consider these methodological approaches:
Allelic Replacement Strategies:
Construct vectors containing upstream and downstream homologous regions flanking the desired modification
Include selectable markers (antibiotic resistance genes) for positive selection
Consider counter-selectable markers (e.g., sacB) for seamless modifications
Optimize homology arm lengths (typically 500-1000 bp) for efficient recombination
Conditional Expression Systems:
For essential genes like rimP, use inducible/repressible promoter systems
Options include tet-responsive elements, IPTG-inducible systems, or riboswitches
Ensure tight regulation to prevent leaky expression
Validate system dynamics using reporter genes before targeting rimP
CRISPR-Cas9 Based Approaches:
Design sgRNAs targeting specific regions of rimP
Provide repair templates for homology-directed repair
Optimize Cas9 expression for N. meningitidis
Screen for off-target effects
Transformation Considerations:
Use piliated strains with high competence
Optimize DNA concentration and methylation status
Consider restriction barriers and use host-mimicking methylation
Include DUS (DNA uptake sequence) elements in constructs
Verification Methods:
PCR verification with primers flanking the modified region
Sequencing to confirm precise modifications
Quantitative RT-PCR for expression changes
Western blotting to verify protein levels
| Method | Advantages | Limitations | Best Application Scenario |
|---|---|---|---|
| Allelic exchange | Well-established, relatively efficient | Time-consuming, multiple recombination events | Complete gene deletion, small modifications |
| Conditional expression | Allows study of essential genes | System leakiness, non-native expression levels | Depletion studies, dominant negative approaches |
| CRISPR-Cas9 | Precise editing, potentially higher efficiency | Optimization for N. meningitidis needed, off-target effects | Point mutations, scarless editing |
| Transposon mutagenesis | High-throughput, genome-wide | Random insertions, polar effects | Initial screening for non-essential regions |
| Antisense RNA | Relatively simple, tunable | Incomplete knockdown, off-target effects | Rapid assessment of gene importance |
Understanding how RimP affects the global proteome of N. meningitidis requires comprehensive analytical approaches that capture both direct effects on translation and indirect consequences of altered ribosome assembly:
Quantitative Proteomics Approaches:
SILAC (Stable Isotope Labeling with Amino acids in Cell culture)
TMT (Tandem Mass Tag) or iTRAQ (Isobaric Tags for Relative and Absolute Quantitation)
Label-free quantification methods
Targeted proteomics (SRM/MRM) for specific proteins of interest
Ribosome Profiling:
Nuclease footprinting of translating ribosomes
Deep sequencing of ribosome-protected fragments
Analysis of translation efficiency across the transcriptome
Identification of translational stalling or frameshifting events
Polysome Analysis:
Sucrose gradient fractionation to separate monosomes from polysomes
RNA-seq of gradient fractions to identify translationally regulated mRNAs
Proteomic analysis of ribosome-associated proteins across fractions
Assessment of non-canonical translation products
Post-translational Modification Analysis:
Phosphoproteomics to detect signaling changes
Analysis of stress-induced modifications
Quantitation of protein stability and turnover rates
Identification of misfolded protein accumulation
Experimental Design Considerations:
When analyzing RimP's impact on the proteome, researchers should employ the principles of:
Randomization: Randomly assign cultures to treatment groups and processing order3
Replication: Include sufficient biological and technical replicates (minimum 3)3
Blocking: Control for batch effects in sample preparation and analysis3
Data Analysis Framework:
Primary Analysis:
Protein identification and quantification
Statistical analysis of differential abundance
Pathway enrichment analysis
Protein-protein interaction network mapping
Secondary Analysis:
Correlation with transcriptomic data
Structural classification of affected proteins
Motif analysis of differentially translated mRNAs
Codon usage bias assessment
Functional Validation:
Targeted deletion or overexpression of key identified proteins
Phenotypic assays to assess functional consequences
In vitro translation assays with purified components
Structural biology approaches for key interactions
| Analytical Approach | Primary Data Output | Strengths | Weaknesses | Key Applications |
|---|---|---|---|---|
| LC-MS/MS with TMT Labeling | Relative protein abundance across conditions | Multiplex capability, high throughput | Ratio compression, complex sample prep | Global proteome shifts |
| SILAC | Precise relative quantification | Accurate ratios, good reproducibility | Limited multiplexing, metabolic labeling required | Direct comparison of wild-type vs. RimP-depleted |
| Ribosome Profiling | Genome-wide translation efficiency | Nucleotide resolution, captures translation dynamics | Complex library prep, high sequencing depth required | Identifying translation efficiency changes |
| Pulse-SILAC | Protein synthesis and degradation rates | Distinguishes synthesis vs. stability effects | Complex experimental setup | Measuring kinetic effects of RimP depletion |
| Proteome Fractionation | Subcellular localization changes | Reveals protein mislocalization | Labor intensive, potential cross-contamination | Understanding trafficking defects |
By combining these approaches, researchers can develop a comprehensive understanding of how RimP influences the N. meningitidis proteome, providing insights into both basic biology and potential therapeutic interventions.
Despite advances in understanding RimP function, significant knowledge gaps remain that present opportunities for future research:
Structural Specificity in N. meningitidis:
While structural information exists for RimP homologs in other species such as M. smegmatis , N. meningitidis-specific structural features remain largely unexplored. Future studies should determine the crystal or cryo-EM structure of N. meningitidis RimP to identify unique structural features that may influence function.
Temporal Dynamics of RimP Action:
The precise timing and dynamics of RimP association and dissociation during ribosome assembly remain unclear. Time-resolved studies using techniques such as single-molecule fluorescence or pulse-chase experiments would provide valuable insights into these dynamics.
Regulatory Mechanisms:
Little is known about how RimP expression and activity are regulated in response to changing environmental conditions. Transcriptomic and proteomic studies under various stress conditions would help elucidate these regulatory networks.
Interactions with Other Assembly Factors:
RimP likely functions within a broader network of ribosome assembly factors. Comprehensive protein-protein interaction studies would help map this network and understand cooperative or competitive interactions.
Host-Pathogen Interactions:
The potential role of RimP in N. meningitidis virulence and host interaction remains unexplored. Studies in infection models could reveal whether RimP-dependent translation affects virulence factor expression.
Future Research Directions:
Comparative Studies:
Cross-species analysis of RimP structure and function
Evolutionary analysis of conserved and variable regions
Identification of species-specific adaptations
Systems Biology Approaches:
Integration of transcriptomic, proteomic, and structural data
Network analysis of ribosome assembly pathways
Mathematical modeling of assembly dynamics
Translational Applications:
High-throughput screening for RimP inhibitors
Structure-based drug design targeting specific RimP interfaces
Development of diagnostic tools based on RimP biology
Technical Innovations:
Application of advanced mass spectrometry for assembly intermediate characterization
Development of RimP-specific biosensors
Single-cell analysis of RimP function
| Research Area | Knowledge Gap | Proposed Methodologies | Potential Impact |
|---|---|---|---|
| Structural Biology | N. meningitidis-specific RimP structure | X-ray crystallography, Cryo-EM | Structure-based drug design opportunities |
| Functional Genomics | Genome-wide effects of RimP depletion | RNA-seq, Ribo-seq, Proteomics | Understanding regulatory networks |
| Drug Discovery | RimP as antimicrobial target | High-throughput screening, Medicinal chemistry | Novel therapeutic approaches |
| Evolutionary Biology | Conservation and divergence across species | Phylogenetic analysis, Structural comparison | Insights into species-specific adaptations |
| Diagnostic Development | RimP as biomarker | Antibody development, PCR-based detection | Improved N. meningitidis diagnostics |